The HPV Self-test as a Test of Cure in Madagascar

NCT02811367 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2016-10-17

No results posted yet for this study

Summary

The purpose of this study is to find out whether Self-HPV may be an accurate method for the follow-up of women with a history of HPV infection.

Conditions

  • Human Papilloma Virus Infection
  • Cervical Intraepithelial Neoplasia Grade 2/3

Interventions

DEVICE

HPV test

Women will perform the HPV self-test and will also undergo a physician-performed HPV test.

Sponsors & Collaborators

  • University Hospital, Geneva

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • Madagascar

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02811367 on ClinicalTrials.gov